GENEVA, Aug. 31 -- CVERGENX, INC. filed a patent application (US2026/015712) for “PRE-DETERMINED GENOMIC ADJUSTED RADIATION DOSE (GARD) VALUES FOR OROPHARYNGEAL CANCER”. With publication no. WO/2026/178156, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61N 5/10
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....